March 20, 2018
Nippon Chemiphar and Nagase Medicals said on March 19 that Japan’s Supreme Court dismissed an appeal by Swiss-based Debiopharm International SA, which sought to block the distribution of generic versions of its anticancer agent Elplat (oxaliplatin). In May 2016, Debiopharm...read more